19702911000001105: Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Alfuzosin\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Alfuzosin\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing alpha adrenergic receptor antagonist\Product containing alpha-1 adrenergic receptor antagonist\Product containing alfuzosin\Alfuzosin\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing alpha adrenergic receptor antagonist\Product containing alpha-1 adrenergic receptor antagonist\Product containing alfuzosin\Alfuzosin\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing alpha adrenergic receptor antagonist\Product containing alpha-1 adrenergic receptor antagonist\Product containing alfuzosin\Product containing alfuzosin in oral dose form (medicinal product form)\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing alfuzosin\Alfuzosin\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing alfuzosin\Alfuzosin\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing alfuzosin\Product containing alfuzosin in oral dose form (medicinal product form)\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing alfuzosin in oral dose form (medicinal product form)\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing alpha adrenergic receptor antagonist\Product containing alpha-1 adrenergic receptor antagonist\Product containing alfuzosin\Alfuzosin\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing alpha adrenergic receptor antagonist\Product containing alpha-1 adrenergic receptor antagonist\Product containing alfuzosin\Alfuzosin\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing alpha adrenergic receptor antagonist\Product containing alpha-1 adrenergic receptor antagonist\Product containing alfuzosin\Product containing alfuzosin in oral dose form (medicinal product form)\Product containing only alfuzosin in oral dose form (medicinal product form)\Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet\Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Dec 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

66650101000001110 Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

78132601000001111 Alfuzosin 2.5mg tablets (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Is a	Product containing precisely alfuzosin hydrochloride 2.5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Has active ingredient	Alfuzosin hydrochloride	false	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Has specific active ingredient	Alfuzosin hydrochloride	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd) 60 tablet	Has AMP	True	Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
66650101000001110	Alfuzosin 2.5mg tablets (Doncaster Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
78132601000001111	Alfuzosin 2.5mg tablets (DE Pharmaceuticals)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module